However, INHBA's increased expression levels in these patients' tumors more likely reflect its product's ability to homodimerize and form activin A, an FSH secretion activator and putative oncogene in esophageal carcinoma [23]. This evidence concerns the gene BRD2 and carcinoma of esophagus.